Racing Victoria (RV) Stewards have today issued two charges against licensed trainer Richard Laming following their investigation into the circumstances that led to the Mr Laming-trained Sly Romance returning a pre-race blood sample containing Triamcinolone Acetonide (a corticosteroid) on 19 May 2018.
The presence of Triamcinolone Acetonide was detected in the blood sample by Racing Analytical Services Limited (RASL) and by the Australian Racing Forensic Laboratory.
Mr Laming has been issued with the following charges under Australian Rules of Racing:
Charge One: AR178 – Presentation of a horse with a prohibited substance
“When any horse that has been brought to a racecourse for the purpose of engaging in a race and a prohibited substance is detected in any sample taken from it prior to or following its running in any race, the trainer and any other person who was in charge of such horse at any relevant time may be penalised.”
The particulars of the charge are summarised as follows:
- On 19 May 2018, Sly Romance was brought to Flemington Racecourse and ran in the Andrew Ramsden Stakes over 3200 metres.
- A prohibited substance, being Triamcinolone Acetonide, (a corticosteroid), was detected in a pre-race blood sample taken from Sly Romance on 19 May 2018.
Charge Two: AR178F(1) – Failure to record treatment and medication administered
- A trainer must record treatment and medication administered to each horse in his or her care by midnight on the day on which the administration was given, and each record must include the following information:
The particulars of the charge are summarised as follows:
- In accordance with AR 178F(1), Mr Laming failed to record in his treatment diary the following treatment and medication administered to Sly Romance on 13 April 2018:
- the intra-articular injection of Kenacort (Triamcinolone Acetonide) and Hyaluronic Acid to the knees and fore fetlocks.
The charges issued against Mr Laming will be heard before the Racing Appeals and Disciplinary (RAD) Board on a date to be fixed.